From: Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
Number of treated patients | Treatment response | Relapse | ||||
---|---|---|---|---|---|---|
Complete response | Partial response | Stable disease | Progressive disease | |||
Alveolar consolidative | 10 | 2 (20.0) | 6 (60.0) | 2 (20.0) | 0 (0.0) | 1 (12.5) |
Solid nodular | 7 | 0 (0.0) | 6 (85.7) | 1 (14.3) | 0 (0.0) | 3 (50.0) |
Bronchovascular | 8 | 0 (0.0) | 7 (87.5) | 1 (12.5) | 0 (0.0) | 1 (14.3) |
Alveolar interstitial | 5 | 0 (0.0) | 2 (40.0) | 3 (60.0) | 0 (0.0) | 0 (0.0) |
Round ground glass opacity | 1 | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) |
Total | 31 | 2 (6.4) | 22 (71.0) | 7 (22.6) | 0 (0.0) | 6 (25.0) |